Research prototype, not medical advice.

In the COLCOT phase III trial, low-dose colchicine reduced ischemic events after a heart attack.

Confidence
Established
Level of evidence
Randomized clinical trial
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Chronic inflammationLow-dose colchicineCardiovascular disease

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Tardif et al. · New England Journal of Medicine 2019
— Verified

Related claims